CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers

Modulation of Immune check point regulators, especially the PD-1/PD-L1 axis, plays a critical role in successful management of a small proportion of lung cancer patients, but not so effective in the rest of lung cancer patients. A better understanding of immunotherapy non-responsive or resistant pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Feng, Chen, Jing, Wang, Jia, Li, Peixiang, Wu, Sheng, Wang, Jue, Ji, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804456/
https://www.ncbi.nlm.nih.gov/pubmed/31646201
http://dx.doi.org/10.1016/j.bbrep.2019.100690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804456/
https://www.ncbi.nlm.nih.gov/pubmed/31646201
http://dx.doi.org/10.1016/j.bbrep.2019.100690

Ejemplares similares